2013
DOI: 10.2337/db12-0866
|View full text |Cite
|
Sign up to set email alerts
|

Detrimental Effects of Diet-Induced Obesity on τ Pathology Are Independent of Insulin Resistance in τ Transgenic Mice

Abstract: The τ pathology found in Alzheimer disease (AD) is crucial in cognitive decline. Midlife development of obesity, a major risk factor of insulin resistance and type 2 diabetes, increases the risk of dementia and AD later in life. The impact of obesity on AD risk has been suggested to be related to central insulin resistance, secondary to peripheral insulin resistance. The effects of diet-induced obesity (DIO) on τ pathology remain unknown. In this study, we evaluated effects of a high-fat diet, given at an earl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
68
1
1

Year Published

2013
2013
2019
2019

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 90 publications
(76 citation statements)
references
References 38 publications
6
68
1
1
Order By: Relevance
“…Animal studies utilizing transgenic mouse models of AD have shown that a diet rich in saturated fat and cholesterol can increase AD-pathology hallmarks, such as amyloid levels, Tau phosphorylation, and behavioral deficits [28][29][30]. Furthermore, diet-induced obesity has been shown to potentiate Tau-pathology in mice [31,32], but it is not known whether these effects are exacerbated with aging, nor is it known whether the Tau phosphorylation cascade is involved in HFHCdiet induced cognitive impairment. Therefore, the aims of this study were to investigate the consequences of long-term consumption of a HFHC diet on cognitive performance, hippocampal morphology, and expression of phosphorylated Tau in young versus aged rats.…”
Section: Introductionmentioning
confidence: 99%
“…Animal studies utilizing transgenic mouse models of AD have shown that a diet rich in saturated fat and cholesterol can increase AD-pathology hallmarks, such as amyloid levels, Tau phosphorylation, and behavioral deficits [28][29][30]. Furthermore, diet-induced obesity has been shown to potentiate Tau-pathology in mice [31,32], but it is not known whether these effects are exacerbated with aging, nor is it known whether the Tau phosphorylation cascade is involved in HFHCdiet induced cognitive impairment. Therefore, the aims of this study were to investigate the consequences of long-term consumption of a HFHC diet on cognitive performance, hippocampal morphology, and expression of phosphorylated Tau in young versus aged rats.…”
Section: Introductionmentioning
confidence: 99%
“…According to the Rotterdam Study, levels of insulin and insulin resistance were associated with a higher risk of AD only within 3 years of baseline (Schrijvers et al 2010). Nevertheless, McNeilly et al (2012) showed that cognitive deficits observed in dietinduced-obese animals were not prevented by insulin sensitizers, while Leboucher et al (2013) have shown that obesity potentiate spatial learning deficits as well as hippocampal tau pathology in τ-transgenic mice, independently of insulin resistance state. Both of these studies have highlighted the relevance of insulin-independent mechanisms in the increased risk of dementia related to obesity.…”
Section: Introductionmentioning
confidence: 99%
“…Metabolic deregulations in animal models of tauopathies resemble those found in patients with Tau-related dementia. Indeed, decreased body weight has been described in a mouse model of Tau deposition such as THY-22 [148] or Tg4510 [149, 150], sometimes despite increased feeding behavior [151]. Additionally, genetic deletion of Tau resulted in increased body weight [152].…”
Section: Brain Insulin Resistance In Ad and Tauopathies: Cause Or Conmentioning
confidence: 99%